We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

116 hedge funds and large institutions have $691M invested in Travere Therapeutics in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 31

52% more call options, than puts

Call options by funds: $61.1M | Put options by funds: $40.2M

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

4% less capital invested

Capital invested by funds: $719M → $691M (-$27.2M)

13% less funds holding

Funds holding: 133 → 116 (-17)

47% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 36

Holders
116
Holders Change
-17
Holders Change %
-12.78%
% of All Funds
3.04%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.21%
New
19
Increased
51
Reduced
31
Closed
36
Calls
$61.1M
Puts
$40.2M
Net Calls
+$20.9M
Net Calls Change
-$22.9M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.9M
2
ACP
Acuta Capital Partners
California
+$7.39M
3
SCM
Scopia Capital Management
New York
+$7.37M
4
BC
Broadfin Capital
New York
+$6.99M
5
SAM
Senzar Asset Management
New York
+$6.73M

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$10.8M
2
Wells Fargo
Wells Fargo
California
-$6.28M
3
QF
QVT Financial
New York
-$6.01M
4
Morgan Stanley
Morgan Stanley
New York
-$4.92M
5
EAM
Eventide Asset Management
Massachusetts
-$4.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
Lord, Abbett & Co
126
Lord, Abbett & Co
New Jersey
– -$1.21M -59,876 Closed
GCP
127
GSA Capital Partners
United Kingdom
– -$993K -48,990 Closed
NI
128
Numeric Investors
Massachusetts
– -$972K -48,000 Closed
JGC
129
J. Goldman & Co
New York
– -$886K -43,734 Closed
Ameriprise
130
Ameriprise
Minnesota
– -$798K -39,380 Closed
PCM
131
Pyrrho Capital Management
New York
– -$750K -37,040 Closed
BCM
132
Bridgeway Capital Management
Texas
– -$670K -33,064 Closed
QIM
133
Quantitative Investment Management
Virginia
– -$664K -32,800 Closed
GAM
134
Gotham Asset Management
New York
– -$512K -25,289 Closed
Susquehanna International Group
135
Susquehanna International Group
Pennsylvania
– -$501K -25,062 Closed
JAM
136
JW Asset Management
Florida
– -$489K -24,147 Closed
HCM
137
Highbridge Capital Management
New York
– -$460K -23,032 Closed
Balyasny Asset Management
138
Balyasny Asset Management
Illinois
– -$384K -18,950 Closed
BFM
139
Boothbay Fund Management
New York
– -$368K -18,185 Closed
SEI Investments
140
SEI Investments
Pennsylvania
– -$338K -16,703 Closed
Dimensional Fund Advisors
141
Dimensional Fund Advisors
Texas
– -$251K -12,369 Closed
Voloridge Investment Management
142
Voloridge Investment Management
Florida
– -$247K -12,209 Closed
1CM
143
1492 Capital Management
Wisconsin
– -$207K -10,200 Closed
Walleye Trading
144
Walleye Trading
New York
– -$73K -3,600 Closed
CSS
145
Cubist Systematic Strategies
Connecticut
– -$73K -3,590 Closed
VCM
146
Vigilant Capital Management
Maine
– -$41K -2,000 Closed
IPC
147
Independent Portfolio Consultants
Florida
– -$27K -1,345 Closed
QT
148
Quantbot Technologies
New York
– -$10K -500 Closed
Acadian Asset Management
149
Acadian Asset Management
Massachusetts
– -$10K -496 Closed
SGAM
150
Smith Group Asset Management
Texas
– -$7K -364 Closed
3 4 5
6
7

TVTX Hedge Fund Activity: Q4 2015 in Review

116 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q4 2015, worth a combined $691M — down 3.8% from $719M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of TVTX and 19 opened new positions — a net loss of 17 holders — while 31 trimmed existing stakes and 51 added.

The largest buyer was Fidelity Investments, adding an estimated $12.9M. The largest seller was Putnam Investments, exiting entirely with an estimated $10.8M sold.

  • 116 institutional investors held Travere Therapeutics (TVTX) as of Q4 2015, down from 133 in Q3 2015.
  • Funds reported $691M of Travere Therapeutics stock for Q4 2015, down 3.8% quarter-over-quarter.
  • 19 funds opened new Travere Therapeutics positions in Q4 2015 and 36 closed out, a net change of -17 holders.
  • The largest Travere Therapeutics buyer in Q4 2015 was Fidelity Investments, an estimated $12.9M added.
  • The largest Travere Therapeutics seller in Q4 2015 was Putnam Investments, an estimated $10.8M sold.

Based on aggregated 13F filings for Q4 2015.